Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 7Peritoneal Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Colorectal Neoplasms 3Carcinoma, Transitional Cell 3Appendiceal Neoplasms 3Urologic Neoplasms 2Urogenital Neoplasms 2Stomach Neoplasms 2Recurrence 2Pseudomyxoma Peritonei 2Ovarian Neoplasms 2Neoplasms by Site 2Neoplasms 2Anus Neoplasms 2Uterine Neoplasms 1Urologic Diseases 1Urogenital Diseases 1Urinary Bladder Diseases 1Sarcoma 1Pleural Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Necrosis 1Mediastinal Neoplasms 1Male Urogenital Diseases 1Gastrointestinal Neoplasms 1Female Urogenital Diseases 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

sodium thiosulfate 1Oxaliplatin 1Mitomycin 1Levetiracetam 1Fluorouracil 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Necrosis × Mitomycin × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡